Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Memorial Sloan Kettering Cancer Center
Y

Frontline Management of Advanced GEJ Cancers: Will 5FU/Oxaliplatin + Nivo Become the New SoC? Does Adjuvant Nivo Show DFS Benefit?

By Memorial Sloan Kettering Cancer Center FEATURING Yelena Y. Janjigian
By Memorial Sloan Kettering Cancer Center FEATURING Yelena Y. Janjigian
408 views
March 4, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Gastrointestinal
04:39
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor …

Feat. G. Abou-Alfa
06:31
ecancer

CheckMate 649 Trial Biomarker Analyses of Nivo + Ipi vs. Chemo for P…

Feat. Y. Y. Janjigian
31:25
Total Health

Updates in Rectal Cancer: Optimizing Response, Preserving the Organ,…

Feat. J. Smith
10:36
CE Concepts

Pathophysiologic Foundations in HCC/BTC: Immune System as a Therapeu…

Feat. J. Harding
11:02
ASCO GI 2023 Conference Coverage

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

Feat. Y. Y. Janjigian
07:43
ASCO GI 2023 Conference Coverage

ASCO GI 2023 ctDNA for Response Assessment in Patients With Anal Can…

Feat. J. Alvarez
06:16
ASCO GI 2023 Conference Coverage

ASCO GI 2023 on Organ Preservation and Total Neoadjuvant Therapy for…

Feat. P. Romesser
38:04
Debbie's Dream Foundation

Advances in IO and Targeted Agents in Gastroesophageal Cancer

Feat. D. Ilson
05:41
ecancer

An Overview of Treatment Advances in Gastric Cancer

Feat. D. Ilson
04:07
ecancer

ASCO 2022: Single-Agent PD-1 Blockade as Curative-Intent Treatment i…

Feat. A. Cercek
09:42
ASCO 2022 Conference Coverage

ASCO 2022 Targeting HER2 Mutation-Positive Advanced Biliary Tract Ca…

Feat. J. Harding
58
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Targeting HER2 Mutation-Positive Advance…

Feat. J. Harding
06:42
ASCO 2022 Conference Coverage

ASCO 2022 on PROOF 301 Trial: Updates on Infigratinib vs. Gemcitabin…

Feat. G. Abou-Alfa
23
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Updates on Infigratinib vs. Gemcitabine …

Feat. G. Abou-Alfa
07:48
ecancer

Tremelimumab and Durvalumab as 1L in Unresectable HCC: Phase 3 HIMAL…

Feat. G. Abou-Alfa
20:26
Collaborative Group of the Americas for Inherited Gastrointestinal Cancers

Incidental Findings From Somatic Testing and Implications for Heredi…

Feat. Z. Stadler
08:15
ASCO GI 2022 Conference Coverage

ASCO GI 2022 on a Quality-Adjusted Time Without Symptoms or Toxicity…

Feat. R. Sugarman
05:49
ASCO GI 2022 Conference Coverage

ASCO GI 2022 Updates on the Dose-Escalation & Dose-Expansion Stu…

Feat. Y. Y. Janjigian
09:30
Memorial Sloan Kettering Cancer Center

ESMO 2021 Update on Nivo + Chemo or Ipi vs. Chemo as 1L Treatment in…

Feat. Y. Y. Janjigian
07:44
Memorial Sloan Kettering Cancer Center

ESMO 2021 Abstract Review on Genomic Landscape of Late-Stage Gastric…

Feat. Y. Y. Janjigian
16:43
Debbie's Dream Foundation

Gastric Cancer: Advances in Systemic Therapy

Feat. D. Ilson
07:10
2021 ASCO Virtual Direct™ Highlights

2021 ASCO CRC Updates: 1L Pembro vs. Chemo, Maintenance Chemo, 2L an…

Feat. L. Connell
09:50
Memorial Sloan Kettering Cancer Center

1L Treatment Updates for Advanced GE/GEJ Cancers: OS Data for Nivo+I…

Feat. Y. Janjigian
21:21
Memorial Sloan Kettering Cancer Center

Frontline Management of Advanced GEJ Cancers: Will 5FU/Oxaliplatin +…

Feat. Y. Y. Janjigian
11:00
Memorial Sloan Kettering Cancer Center

BRAF Alterations in Advanced CRC: How Common Are V600E Mutations? Ho…

Feat. R. Yaeger
17:05
Memorial Sloan Kettering Cancer Center

Liver-Directed Therapy for mCRC: What Is the Goal, When to Use and H…

Feat. A. Cercek
13:27
2020 Virtual ESMO Review

2020 ESMO Update on mPDAC: Does the Addition of Dual Immune Checkpoi…

Feat. L. Connell
08:07
2020 Virtual ESMO Review

2020 ESMO Update on Metastatic Pancreatic Cancer: What Does the Qoli…

Feat. L. Connell
11:33
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Locoregional CRC: 3 vs. 6 Months of Adjuvant Oxa…

Feat. L. Connell
09:21
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced CRC: Should Pembrolizumab Be The New So…

Feat. L. Connell
14:43
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced CRC: Is Recently FDA Approved Encorafen…

Feat. L. Connell
22:02
Memorial Sloan Kettering Cancer Center

The Role of Modern RT Techniques in Management of Esophagogastric Ca…

Feat. A. Wu
18:32
Memorial Sloan Kettering Cancer Center

Advanced Surgical Techniques for Early Stage Esophagogastric Cancer:…

Feat. D. Molena
20:17
Memorial Sloan Kettering Cancer Center

Current and Future Personalized Systemic Targets in Esophagogastric …

Feat. G. Ku